Good Sense Suphedrine Tablet, Film Coated, Extended Release
NDC Package 0113-0054-52
Package Information
Good Sense Suphedrine (pseudoephedrine hydrochloride) tablets is adults and children 12 years and over•take 1 tablet every 12 hours•do not take more than 2 tablets in 24 hourschildren under 12 yearsdo not use this product in children under 12 years of age. This formulation utilizes a tablet, film coated, extended release delivery system. Marketed by L. Perrigo Company, this product is identified by NDC 0113-0054 and is authorized under FDA application ANDA075153.
Identification & Billing
- RxCUI: 1049154 - pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet
- RxCUI: 1049154 - 12 HR pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet
- RxCUI: 1049154 - pseudoephedrine HCl 120 MG 12 HR Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0113 - L. Perrigo Company
- 0113-0054 - Good Sense Suphedrine
- 0113-0054-52 - 10 BLISTER PACK in 1 CARTON / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
- 0113-0054 - Good Sense Suphedrine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0113-0054-52 identifies a specific commercial package of 10 blister pack in 1 carton / 1 tablet, film coated, extended release in 1 blister pack of Good Sense Suphedrine 12 Hour, a human over the counter drug labeled by L. Perrigo Company. This tablet, film coated, extended release is formulated for oral use and contains pseudoephedrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by L. Perrigo Company on October 29, 1999. The current certification is valid through December 31, 2026.
How is this L. Perrigo Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00113005452. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.